Apolipoprotein A1, APOA1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Apolipoprotein A1, APOA1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityApolipoprotein A1, APOA1
Clonepolyclonal
Host SpeciesMouse
Reactive Specieshuman
Isotypen/a
FormatProtein A purified
Size0.1 mg
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionApolipoprotein A-I (APOA1) is the major protein component of high density lipoprotein (HDL) in plasma. [1] Chylomicrons secreted from the intestinal enterocyte also contain ApoA1 but it is quickly transferred to HDL in the bloodstream. [2]It was composed of an N-terminal 4-helix bundle with a hydrophobic core and 2 C-terminal helices. [3] It has an approximate molecular weight of 28 KDa. A G/A polymorphism in the promoter of the ApoA-I gene has been associated with the age at which patients presented with Alzheimer disease. [4] Protection from Alzheimer disease by ApoA1 may rely on a synergistic interaction with alpha-tocopherol. [5]
ImmunogenImmunogen: A synthetic peptide (conjugated with KLH) corresponding to the region of human APOA1.
Other Namesn/a
Gene, Accession #[APOA1], NCBI: CAA00975.1
Catalog #MBS355173
Price$275
Order / More InfoApolipoprotein A1, APOA1 Antibody from MYBIOSOURCE INC.
Product Specific References1. Breslow, J. L., Ross, D., McPherson, J., Williams, H., Kurnit, D., Nussbaum, A. L., Karathanasis, S. K., Zannis, V. I. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc. Nat. Acad. Sci. 79: 6861-6865, 1982. 2. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ (january 2008). Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nature Reviews Drug Discovery 7 (1): 84-99. 3. Ajees, A. A., Anantharamaiah, G. M., Mishra, V. K., Hussain, M. M., Murthy, H. M. K. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Nat. Acad. Sci. 103: 2126-2131, 2006. 4. Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kolsch H (2005). APOA1 polymorphism influences risk for early-onset nonfamiliar AD. Ann. Neurol. 58 (3): 436-41. 5. Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, Montine KS (2004). Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J. Neurochem. 91 (6): 1312-21.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.